Streetbeat News

Price Targets

CMA

Morgan Stanley analyst Manan Gosalia maintains an Equal-Weight rating on Comerica (NYSE:CMA) and raises the price target from $61 to $63.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 4:24 pm

FITB

Morgan Stanley analyst Manan Gosalia maintains an Equal-Weight rating on Fifth Third Bancorp (NASDAQ:FITB) and raises the price target from $47 to $51.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 4:22 pm

EWBC

Morgan Stanley analyst Manan Gosalia maintains an Overweight rating on East West Bancorp (NASDAQ:EWBC) and raises the price target from $103 to $106.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 4:19 pm

GOOGL

Cantor Fitzgerald has reiterated a Neutral rating on Alphabet (NASDAQ:GOOGL) and maintained a price target of $190.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 4:16 pm

ADBE

Whales are showing a bullish stance on Adobe (NASDAQ:ADBE) with significant options activity. Analysts have set an average price target of $619, with some as high as $675. The stock is currently trading at $515.29, slightly down, and may be approaching oversold territory.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 4:15 pm

PANW

Palo Alto Networks (NASDAQ:PANW) has seen significant bullish options activity, with 52% of trades being bullish. The stock is currently trading at $340.38, up 1.38%. Analysts have set an average price target of $420.0, with Susquehanna maintaining a Positive rating.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 4:15 pm

C

Morgan Stanley analyst Betsy Graseck maintains an Overweight rating on Citigroup and raises the price target from $79 to $86.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 4:15 pm

GDDY

Cantor Fitzgerald analyst Deepak Mathivanan has reiterated a Neutral rating on GoDaddy (NYSE:GDDY) and maintained a price target of $170.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 4:14 pm

MRNS

EF Hutton has initiated coverage on Marinus Pharma with a Buy rating and set a price target of $23, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 4:13 pm

EXPE

Cantor Fitzgerald analyst Deepak Mathivanan has reiterated a Neutral rating on Expedia Group (NASDAQ:EXPE) and maintained a price target of $130.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 4:12 pm